European Archives - Page 26 of 1259 - European Medical Journal

Prior Dengue Infection Reshapes Immune Response to Vaccine

Prior dengue infection reshapes innate immunity, boosting vaccine efficacy. Vaccination alone fails to replicate these immune changes.

Skin Cancer Risks Identified in Key Autoimmune Conditions

Discover a study linking select autoimmune diseases with increased risks of melanoma and non-melanoma skin cancers, highlighting the need for closer surveillance.

16 Sep 2025

Effectiveness of Berotralstat▼ for Hereditary Angioedema Prophylaxis

What does effective prophylaxis look like for people living with hereditary angioedema (HAE)? In this new interactive article, two leading…

AI Accelerates Antibody Discovery for Pandemic Preparation

New AI imaging method speeds up antibody discovery for infectious disease treatments, fuelling global pandemic preparedness efforts.

Improving Prostate Cancer Outcomes with Updated Risk Models

By aligning pretreatment risk stratification more closely with AS eligibility, clinicians may feel more confident recommending surveillance, potentially reducing overtreatment.

Caesarean Births Rise to Record High Across Britain

Over half of all births in Britain now involve medical intervention, with caesarean deliveries driving the trend, new NHS data show.

How Childhood Cognitive Skills Influence Lifespan

Childhood cognitive skills linked to lower mortality risk, but adversity may weaken these protective effects into adulthood.

Paediatric Infectious Diseases: RSV in Infants and Maternal Protection

Gonzalo Pérez Marc, paediatrician and clinical researcher, shares insights from the BERNI study on maternal RSV vaccination and strategies to protect infants worldwide.

How Blueberries May Reduce Allergy Risk in Infants

Previous research has shown that blueberry intake in adults increases beneficial Bifidobacterium species, enhances gut barrier integrity, and reduces inflammation.

Does Besifovir Reduce Hepatocellular Carcinoma Risk?

Potential mechanisms behind BSV’s protective effect may mirror those described for tenofovir-based therapies, such as modulation of inflammatory and oncogenic pathways.